LAS VEGAS, June 13, 2023 /PRNewswire/ — Heligenics, a cutting-edge biotech company, announces a first-of-its-kind precision genetic test to select among drugs to treat breast cancer. This will transform analysis of biopsies to create a data-driven approach to treatment. There are…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.